Literature DB >> 20065055

Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals.

Li-Yang Hsu1, Thean-Yen Tan, Vincent H Tam, Andrea Kwa, Dale Andrew Fisher, Tse-Hsien Koh.   

Abstract

A surveillance study was performed in four Singapore public hospitals from 2006 to 2008 to determine the correlation between antibiotic prescription and Gram-negative bacterial antimicrobial resistance. Targeted organisms included ceftriaxone- and ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae, as well as imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. Antibiotic prescription data were collated in the WHO anatomical therapeutic chemical (ATC)/defined daily dose (DDD) format, while antibiotic resistance was expressed as incidence density adjusted for total inpatient-days every quarter. Individual trends were determined by linear regression, while possible associations between antibiotic prescription and resistance were evaluated via cross-correlation analysis. Results over 3 years indicated significantly rising incidence densities of ceftriaxone- and ciprofloxacin-resistant E. coli and imipenem-resistant Acinetobacter spp. (blood isolates only). Antimicrobial-resistant Klebsiella pneumoniae rates declined. The prescription rates of piperacillin-tazobactam, ertapenem, meropenem, ciprofloxacin, and levofloxacin increased significantly, while imipenem and moxifloxacin prescription decreased. Cross-correlation analysis demonstrated possible associations between prescription of fluoroquinolones and ciprofloxacin-resistant E. coli (R(2) = 0.46), fluoroquinolones and ceftriaxone-resistant E. coli (R(2) = 0.47), and carbapenems and imipenem-resistant Acinetobacter spp. (R(2) = 0.48), all at zero time lag. Changes in meropenem prescription were associated with a similar trend in imipenem-resistant Acinetobacter blood isolates after a 3-month time lag. No correlation was found between cephalosporin use and resistance. In conclusion, our data demonstrated correlation between prescription of and Gram-negative bacterial resistance to several, but not all, key antimicrobial agents in Singapore hospitals. In areas where Gram-negative bacterial resistance is endemic and prescription of broad-spectrum antimicrobial agents is high, factors other than antimicrobial usage may be equally important in maintaining high resistance rates.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065055      PMCID: PMC2826017          DOI: 10.1128/AAC.01076-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption.

Authors:  Alessandro Bartoloni; Filippo Bartalesi; Antonia Mantella; Emanuela Dell'Amico; Mimmo Roselli; Marianne Strohmeyer; Herlan Gamboa Barahona; Virgilio Prieto Barrón; Franco Paradisi; Gian Maria Rossolini
Journal:  J Infect Dis       Date:  2004-03-16       Impact factor: 5.226

2.  Antibiotic use and resistance--proving the obvious.

Authors:  John Turnidge; Keryn Christiansen
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

Review 3.  Gram-negative resistance in Singapore: a historical perspective.

Authors:  Tse Hsien Koh
Journal:  Ann Acad Med Singapore       Date:  2008-10       Impact factor: 2.473

Review 4.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

Authors:  Helen W Boucher; George H Talbot; John S Bradley; John E Edwards; David Gilbert; Louis B Rice; Michael Scheld; Brad Spellberg; John Bartlett
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

Review 5.  Is antimicrobial resistance in hospital microorganisms related to antibiotic use?

Authors:  J E McGowan
Journal:  Bull N Y Acad Med       Date:  1987-04

Review 6.  Antimicrobial resistance in hospital organisms and its relation to antibiotic use.

Authors:  J E McGowan
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

7.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

8.  Association between antimicrobial consumption and resistance in Escherichia coli.

Authors:  Miika Bergman; Solja T Nyberg; Pentti Huovinen; Pirkko Paakkari; Antti J Hakanen
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

Review 9.  The current state of multidrug-resistant gram-negative bacilli in North America.

Authors:  Anthony M Nicasio; Joseph L Kuti; David P Nicolau
Journal:  Pharmacotherapy       Date:  2008-02       Impact factor: 4.705

10.  Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.

Authors:  Po-Ren Hsueh; Wen-Hwei Chen; Kwen-Tay Luh
Journal:  Int J Antimicrob Agents       Date:  2005-11-08       Impact factor: 5.283

View more
  41 in total

1.  Utility and safety of procalcitonin in an antimicrobial stewardship program (ASP) in patients with malignancies.

Authors:  Y X Liew; W Lee; Y Y Cai; J Teo; S S-L Tang; R W-Q Ong; C L-L Lim; P B Lingegowda; A L-H Kwa; M P Chlebicki
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-08       Impact factor: 3.267

2.  Mathematical model to quantify the effects of risk factors on carbapenem-resistant Acinetobacter baumannii.

Authors:  Michelle W Tan; David C Lye; Tat-Ming Ng; Michael Nikolaou; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

3.  Prospective audit and feedback on antibiotic prescription in an adult hematology-oncology unit in Singapore.

Authors:  C-L Yeo; D S-G Chan; A Earnest; T-S Wu; S-F Yeoh; R Lim; R Jureen; D Fisher; L-Y Hsu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-04       Impact factor: 3.267

4.  Systematic analysis of the relationship between antibiotic use and extended-spectrum beta-lactamase resistance in Enterobacteriaceae in a French hospital: a time series analysis.

Authors:  M-A Vibet; J Roux; E Montassier; S Corvec; M-E Juvin; C Ngohou; D Lepelletier; E Batard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-24       Impact factor: 3.267

5.  mcr-1 in Multidrug-Resistant blaKPC-2-Producing Clinical Enterobacteriaceae Isolates in Singapore.

Authors:  Jocelyn Qi-Min Teo; Rick Twee-Hee Ong; Eryu Xia; Tse-Hsien Koh; Chiea-Chuen Khor; Shannon Jing-Yi Lee; Tze-Peng Lim; Andrea Lay-Hoon Kwa
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 6.  Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia.

Authors:  Li-Yang Hsu; Anucha Apisarnthanarak; Erum Khan; Nuntra Suwantarat; Abdul Ghafur; Paul Anantharajah Tambyah
Journal:  Clin Microbiol Rev       Date:  2016-10-19       Impact factor: 26.132

Review 7.  Ten-year narrative review on antimicrobial resistance in Singapore.

Authors:  Alvin Qijia Chua; Andrea Lay-Hoon Kwa; Thean Yen Tan; Helena Legido-Quigley; Li Yang Hsu
Journal:  Singapore Med J       Date:  2019-08       Impact factor: 1.858

8.  Health care associated infections, antibiotic resistance and clinical outcome: A surveillance study from Sanandaj, Iran.

Authors:  Jafar Soltani; Bahman Poorabbas; Neda Miri; Jalal Mardaneh
Journal:  World J Clin Cases       Date:  2016-03-16       Impact factor: 1.337

9.  Surveillance of multidrug resistant uropathogenic bacteria in hospitalized patients in Indian.

Authors:  Monali Priyadarsini Mishra; Nagen Kumar Debata; Rabindra Nath Padhy
Journal:  Asian Pac J Trop Biomed       Date:  2013-04

10.  Time series analysis as a tool to predict the impact of antimicrobial restriction in antibiotic stewardship programs using the example of multidrug-resistant Pseudomonas aeruginosa.

Authors:  Matthias Willmann; Matthias Marschal; Florian Hölzl; Klaus Schröppel; Ingo B Autenrieth; Silke Peter
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.